Literature DB >> 24045946

Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor β2.

Lingfang Zeng1, Gang Wang, Dario Ummarino, Andriana Margariti, Qihe Xu, Qingzhong Xiao, Wen Wang, Zhongyi Zhang, Xiaoke Yin, Manuel Mayr, Gillian Cockerill, Julie Yi-shuan Li, Shu Chien, Yanhua Hu, Qingbo Xu.   

Abstract

Histone deacetylase 3 (HDAC3) plays a critical role in the maintenance of endothelial integrity and other physiological processes. In this study, we demonstrated that HDAC3 undergoes unconventional splicing during stem cell differentiation. Four different splicing variants have been identified, designated as HD3α, -β, -γ, and -δ, respectively. HD3α was confirmed in stem cell differentiation by specific antibody against the sequences from intron 12. Immunofluorescence staining indicated that the HD3α isoform co-localized with CD31-positive or α-smooth muscle actin-positive cells at different developmental stages of mouse embryos. Overexpression of HD3α reprogrammed human aortic endothelial cells into mesenchymal cells featuring an endothelial-to-mesenchymal transition (EndMT) phenotype. HD3α directly interacts with HDAC3 and Akt1 and selectively activates transforming growth factor β2 (TGFβ2) secretion and cleavage. TGFβ2 functioned as an autocrine and/or paracrine EndMT factor. The HD3α-induced EndMT was both PI3K/Akt- and TGFβ2-dependent. This study provides the first evidence of the role of HDAC3 splicing in the maintenance of endothelial integrity.

Entities:  

Keywords:  Cardiovascular; Endothelial Cell; Epithelial to Mesenchymal Transition; Histone Deacetylase; Transforming Growth Factor beta (TGFbeta)

Mesh:

Substances:

Year:  2013        PMID: 24045946      PMCID: PMC3814778          DOI: 10.1074/jbc.M113.463745

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Endothelial cell diversity revealed by global expression profiling.

Authors:  Jen-Tsan Chi; Howard Y Chang; Guttorm Haraldsen; Frode L Jahnsen; Olga G Troyanskaya; Dustin S Chang; Zhen Wang; Stanley G Rockson; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

2.  Sturctural analysis of endocardial cytodifferentiation.

Authors:  R R Markwald; T P Fitzharris; W N Smith
Journal:  Dev Biol       Date:  1975-01       Impact factor: 3.582

3.  Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Authors:  Aled Clayton; J Paul Mitchell; Jacquelyn Court; Malcolm D Mason; Zsuzsanna Tabi
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 4.  Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP).

Authors:  Y Nakajima; T Yamagishi; S Hokari; H Nakamura
Journal:  Anat Rec       Date:  2000-02-01

5.  Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta.

Authors:  J D Potts; R B Runyan
Journal:  Dev Biol       Date:  1989-08       Impact factor: 3.582

Review 6.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

7.  Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.

Authors:  Regalla Kumarswamy; Ingo Volkmann; Virginija Jazbutyte; Seema Dangwal; Da-Hee Park; Thomas Thum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

8.  Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

Authors:  Elisabeth M Zeisberg; Scott E Potenta; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

9.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.

Authors:  Elisabeth M Zeisberg; Scott Potenta; Liang Xie; Michael Zeisberg; Raghu Kalluri
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

10.  Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.

Authors:  Jeannine S Strobl; Meredith Cassell; Sheila M Mitchell; Christopher M Reilly; David S Lindsay
Journal:  J Parasitol       Date:  2007-06       Impact factor: 1.276

View more
  15 in total

1.  MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.

Authors:  Yan-Ping Xu; Qi He; Zheng Shen; Xiao-Li Shu; Chen-Hong Wang; Jia-Jun Zhu; Li-Ping Shi; Li-Zhong Du
Journal:  Hypertens Res       Date:  2017-02-02       Impact factor: 3.872

2.  Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.

Authors:  Harika Sabbineni; Arti Verma; Payaningal R Somanath
Journal:  J Cell Physiol       Date:  2018-06-01       Impact factor: 6.384

3.  14-3-3epsilon controls multiple developmental processes in the mouse heart.

Authors:  Adriana C Gittenberger-de Groot; Tamara Hoppenbrouwers; Lucile Miquerol; Yasuhiro Kosaka; Robert E Poelmann; Lambertus J Wisse; H Joseph Yost; Monique R M Jongbloed; Marco C Deruiter; Luca Brunelli
Journal:  Dev Dyn       Date:  2016-09-18       Impact factor: 3.780

Review 4.  Histone deacetylases and cardiovascular cell lineage commitment.

Authors:  Jun-Yao Yang; Qian Wang; Wen Wang; Ling-Fang Zeng
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 5.  Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker
Journal:  J Am Coll Cardiol       Date:  2019-01-22       Impact factor: 24.094

6.  Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.

Authors:  Sheng-Mao Wu; Yee-Jee Jan; Shih-Chuan Tsai; Hung-Chuan Pan; Chin-Chang Shen; Cheng-Ning Yang; Shu-Hua Lee; Shing-Hwa Liu; Li-Wei Shen; Chien-Shan Chiu; Jack L Arbiser; Menghsiao Meng; Meei-Ling Sheu
Journal:  Cell Biol Toxicol       Date:  2022-01-01       Impact factor: 6.691

7.  Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2.

Authors:  César Echeverría; Ignacio Montorfano; Pablo Tapia; Claudia Riedel; Claudio Cabello-Verrugio; Felipe Simon
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

Review 8.  Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease.

Authors:  Zi-Ying Wang; Wen Qin; Fan Yi
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

9.  Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype.

Authors:  Laura Lecce; Yang Xu; Bhargavi V'Gangula; Nirupama Chandel; Venu Pothula; Axelle Caudrillier; Maria Paola Santini; Valentina d'Escamard; Delaine K Ceholski; Przemek A Gorski; Lijiang Ma; Simon Koplev; Martin Mæng Bjørklund; Johan Lm Björkegren; Manfred Boehm; Jacob Fog Bentzon; Valentin Fuster; Ha Won Kim; Neal L Weintraub; Andrew H Baker; Emily Bernstein; Jason C Kovacic
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

10.  Unspliced X-box-binding protein 1 (XBP1) protects endothelial cells from oxidative stress through interaction with histone deacetylase 3.

Authors:  Daniel Martin; Yi Li; Junyao Yang; Gang Wang; Andriana Margariti; Zhixin Jiang; Hui Yu; Anna Zampetaki; Yanhua Hu; Qingbo Xu; Lingfang Zeng
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.